Dr. Shook is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1845 4th St
San Francisco, CA 94143- Is this information wrong?
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2007 - 2010
Johns Hopkins UniversityResidency, Pediatrics, 2004 - 2007- Johns Hopkins University School of MedicineClass of 2004
Purdue UniversityBS, Biology, Distinction; Honors Degree, 1996 - 2000
Certifications & Licensure
CA State Medical License 2020 - 2024
FL State Medical License 2015 - 2021
TN State Medical License 2007 - 2015- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors Start of enrollment: 2008 Sep 01
- Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia Start of enrollment: 2009 Oct 01
- A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas Start of enrollment: 2012 Aug 20
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsAutologous hematopoietic cell transplantation for the treatment of relapsed/refractory pediatric, adolescent, and young adult Hodgkin lymphoma: a single institutional ...Aimee C Talleur, Jamie E. Flerlage, David Shook, Abigail M Chilsen, Melissa M. Hudson, Cheng Cheng, Sujuan Huang, Brandon M. Triplett> ;Bone Marrow Transplantation. 2020 Apr 9
- 12 citationsSafety of Autologous Umbilical Cord Blood Therapy for Acquired Sensorineural Hearing Loss in Children.Linda S. Baumgartner, Ernest J. Moore, David Shook, Steven A. Messina, Mary Clare Day, Jennifer Greif Green, Rajesh Nandy, Michael D. Seidman, James E. Baumgartner> ;Journal of Audiology & Otology. 2018 Aug 22
- 39 citationsSelective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion.Brandon M. Triplett, Brad Muller, Guolian Kang, Ying Li, Shane J Cross, Joseph Moen, Lea Cunningham, William E. Janssen, Ewelina Mamcarz, David Shook, Ashok Srinivasan...> ;Transplant Infectious Disease. 2018 Feb 1
- Join now to see all
Journal Articles
- Selective T‐Cell Depletion Targeting CD45RA Reduces Viremia and Enhances Early T‐Cell Recovery Compared with CD3‐Targeted T‐Cell DepletionBrandon M Triplett, David R Shook, Ewelina Mamcarz, Randall T Hayden, Shane J Cross, Ashok Srinivasan, Transplant Infectious Disease
Press Mentions
- Nkarta Appoints David R. Shook, MD, as Vice President, Clinical DevelopmentMay 16th, 2022
- Nkarta Appoints David R. Shook, MD, as Vice President, Clinical DevelopmentMay 16th, 2022
- Nkarta Appoints David R. Shook, MD, as Vice President, Clinical DevelopmentMay 16th, 2022
- Join now to see all
Hospital Affiliations
UCSF Benioff Childrens HospitalSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
